Cabergoline 0.25–0.5 mg — 8 Tablets
A dopamine agonist that signals the pituitary to release less prolactin. Lab-driven support for hormonal balance and sexual function goals.
Rx only — requires provider review
Save $7.50
Strength
Purchase option
Supply
Cabergoline is a dopamine receptor agonist. It stimulates dopamine receptors in the pituitary gland, which signals the pituitary to release less prolactin — the hormone that, when elevated, can interfere with libido, sexual function, and hormonal balance in both men and women.
It is typically prescribed when blood work shows elevated prolactin, or within provider-directed protocols where prolactin management supports the broader treatment goal. Because it acts on a specific hormonal signal, lab work drives both the decision to prescribe and the follow-up.
Cabergoline is used under medical supervision with monitoring built into the plan. OpenDoseRx treatments are dispensed only after a licensed provider reviews your health intake and determines a prescription is appropriate for you.
How ordering works
Choose your strength
Pick the exact dose and pack size. You see the price before you commit — nothing is hidden until checkout.
A provider reviews your intake
Complete a short medical intake. An independent, licensed U.S. provider decides if it's appropriate — and if they decline, you're refunded in full.
Compounded and shipped
Approved orders are prepared by a licensed U.S. pharmacy and shipped discreetly to your door.
How cabergoline is understood to act on dopamine and prolactin
A plain-language look at how a dopamine agonist is understood to engage the D2 receptor and reinforce the body's natural control of prolactin.
How testosterone works in the body: the androgen pathway
A plain-language look at testosterone as an androgen and how androgen-receptor signaling is understood to act on tissues across the body.
How enclomiphene is understood to act on the HPG axis
An educational overview of how enclomiphene is understood to interact with the hypothalamic-pituitary-gonadal axis through estrogen-receptor modulation.
